文献速递生殖医学

运动、饮食和/或药物干预对超重或肥胖育龄女性BMI、排卵及激素谱的比较疗效:系统综述与网络Meta分析

Comparative efficacy of exercise, diet and/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis.
PubMed 文献 · Hum Reprod Update · 2024-01-01

该系统综述与网络Meta分析检索截至2023年12月14日的随机对照试验,纳入95项试验(9910名女性),比较运动、饮食和/或药物干预对超重或肥胖育龄女性BMI、排卵及激素谱的疗效。结果显示饮食联合减重药物降低BMI最显著,运动联合饮食及促排卵药提高排卵率最显著,运动联合饮食及减重药物降低睾酮最有效。作者认为联合干预对减重、改善排卵及雄激素正常化有效,但需更高质量研究。

要点

  • 饮食联合减重药物降低BMI最显著(MD -2.61 kg/m2,95%CI -3.04至-2.19)
  • 运动联合饮食及促排卵药提高排卵率最显著(RR 7.15,95%CI 1.94-26.40)
  • 运动联合饮食及减重药物降低睾酮最有效(SMD -2.91,95%CI -4.07至-1.74)

核心结论

  • 运动、饮食和药物干预联合对超重或肥胖女性减重、改善排卵及雄激素正常化有效。
  • 作者认为,尽管需要更高质量研究,结果支持在共同决策中考虑运动、饮食和药物干预。

研究设计与样本

  • 系统综述与频率随机效应网络Meta分析,检索PubMed、Scopus、Web of Science、PsycINFO和Cochrane Library截至2023年12月14日。
  • 纳入95项随机对照试验,共9910名超重或肥胖育龄女性,其中53%存在高或不明确偏倚风险。
  • 主要结局为BMI和排卵率,次要结局为血清生殖激素水平。
  • 进行敏感性分析,仅纳入多囊卵巢综合征(PCOS)女性。

主要发现

  • 与对照相比,饮食联合减重药物降低BMI的MD为-2.61 kg/m2(95%CI -3.04至-2.19;τ2=0.22),运动联合饮食降低BMI的MD为-2.35 kg/m2(95%CI -2.81至-1.89;τ2=0.22)。
  • 与对照相比,运动联合饮食及促排卵药提高排卵率的RR为7.15(95%CI 1.94-26.40;τ2=0.07),运动联合饮食及减重药物的RR为4.80(95%CI 1.67-13.84;τ2=0.07)。
  • 运动联合饮食及减重药物降低睾酮水平的SMD为-2.91(95%CI -4.07至-1.74;τ2=2.25),提高性激素结合球蛋白水平的SMD为2.37(95%CI 0.99-3.76;τ2=2.48),降低游离雄激素指数的SMD为-1.59(95%CI -3.18至0.01;τ2=1.91)。
  • 累积排名曲线下面积评分提示,饮食联合减重药物最可能(94%)产生最大BMI降低,运动联合饮食及促排卵药最可能(89%)产生最大排卵率改善。
  • 仅纳入PCOS女性的敏感性分析结果与上述结果一致。

临床怎么用

  • 作者认为,对于希望妊娠的超重或肥胖女性,最佳治疗策略应在共同决策过程中考虑运动、饮食和药物干预。

局限性

  • 53%的试验存在高或不明确偏倚风险。
  • 需要更高质量的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The increasing prevalence of obesity worldwide poses a significant threat to reproductive function owing, in part, to hormonal disturbances caused by negative feedback between excess adiposity and the hypothalamic-pituitary-ovarian axis. Consequently, finding the most appropriate strategies to lose weight and improve ovulation in women with overweight or obesity is a clinically relevant matter that needs to be investigated. A comprehensive comparison of the independent and combined efficacy of lifestyle and/or pharmacological interventions on BMI, ovulation, and hormonal profile in women with overweight or obesity at risk of anovulatory infertility would facilitate improving fertility strategies in this population. OBJECTIVE AND RATIONALE: This study aimed to evaluate the comparative efficacy of exercise, diet, and pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity. SEARCH METHODS: A systematic review was performed by searching PubMed, Scopus, Web of Science, PsycINFO, and Cochrane Library up to 14 December 2023, for randomized controlled trials assessing the effects of exercise, diet and/or pharmacological interventions (i.e. weight-lowering drugs or ovulation inducers) on BMI, ovulation, and/or hormonal profile in reproductive-aged women with overweight or obesity. We performed frequentist random-effect network meta-analyses and rated the certainty of the evidence. The primary outcomes were BMI and ovulation rate, and the secondary outcomes were serum reproductive hormone levels (gonadotrophins, androgens, or oestrogens). We performed sensitivity analyses, including the studies that only involved women with PCOS. OUTCOMES: Among 1190 records screened, 148 full texts were assessed for eligibility resulting in 95 trials (9910 women), of which 53% presented a high or unclear risk of bias. The network meta-analyses revealed that, compared to control: diet combined with weight-lowering drugs (mean difference (MD) -2.61 kg/m2; 95% CI -3.04 to -2.19; τ2 = 0.22) and adding exercise (MD -2.35 kg/m2; 95% CI -2.81 to -1.89; τ2 = 0.22) led to the greatest decrease in BMI; exercise combined with diet and ovulation inducers (risk ratio (RR) 7.15; 95% CI 1.94-26.40; τ2 = 0.07) and exercise combined with diet and weight-lowering drugs (RR 4.80; 95% CI 1.67-13.84; τ2 = 0.07) produced the highest increase in ovulation rate; and exercise combined with diet and weight-lowering drugs was the most effective strategy in reducing testosterone levels (standardized mean difference (SMD) -2.91; 95% CI -4.07 to -1.74; τ2 = 2.25), the third most effective strategy in increasing sex hormone-binding globulin levels (SMD 2.37; 95% CI 0.99-3.76; τ2 = 2.48), and it was coupled with being ranked first in terms of free androgen index reduction (SMD -1.59; 95% CI -3.18 to 0.01; τ2 = 1.91). The surface under the cumulative ranking curve scores suggested that: diet combined with weight-lowering drugs is the strategy most likely (94%) to produce the highest BMI reduction; and exercise combined with diet and ovulation inducers is the strategy most likely (89%) to produce the highest ovulation rate improvement. The sensitivity analyses, which exclusively included studies involving women diagnosed with PCOS, were consistent with the results presented above. WIDER IMPLICATIONS: Overall, the findings of this network meta-analysis indicate that the combination of exercise, diet, and pharmacological interventions is effective for weight loss, improving ovulation, and normalizing the androgen levels of women with overweight or obesity. Although higher quality studies are needed, these results support that the optimal treatment strategy for women with overweight or obesity wishing to conceive must consider exercise, diet, and pharmacological interventions during the shared decision-making process.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Ruiz-González D, Cavero-Redondo I, Hernández-Martínez A, et al. Comparative efficacy of exercise, diet and/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis. Hum Reprod Update. 2024. PMID: 38627233. doi:10.1093/humupd/dmae008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。